ENTRY       K17341                      KO
NAME        HMCN
DEFINITION  hemicentin
DISEASE     H00821  Macular degeneration
GENES       HSA: 256158(HMCN2) 83872(HMCN1)
            PTR: 457586(HMCN1)
            PPS: 100987660(HMCN1) 100992333(HMCN2)
            GGO: 101145994(HMCN1) 101154358
            PON: 100434687(HMCN2) 100437690(HMCN1)
            MCC: 714026
            MCF: 102136782(HMCN2) 102138170(HMCN1)
            MMU: 545370(Hmcn1) 665700(Hmcn2)
            RNO: 289094(Hmcn1) 686132(Hmcn2)
            CGE: 100756726(Hmcn1) 100758433(Hmcn2)
            HGL: 101697358(Hmcn2) 101698188(Hmcn1)
            TUP: 102497116 102497807(HMCN2)
            CFA: 490318(HMCN1) 491293(HMCN2)
            AML: 100476195
            FCA: 101083136(HMCN1) 101097281(HMCN2)
            PTG: 102960035(HMCN2) 102972141(HMCN1)
            BTA: 521326(HMCN1) 534512(HMCN2)
            BOM: 102272057(HMCN2) 102279445(HMCN1)
            PHD: 102329497(HMCN1) 102343267(HMCN2)
            CHX: 102175882(HMCN1) 102183523(HMCN2)
            SSC: 100519617
            CFR: 102508918(HMCN2) 102511228(HMCN1)
            BACU: 102997345 103006760(HMCN2)
            LVE: 103073391(HMCN2) 103086891
            ECB: 100052277(HMCN1) 100069798(HMCN2)
            MYB: 102257596(HMCN2) 102263923(HMCN1)
            MYD: 102761149 102761717(HMCN1) 102764974(HMCN2) 102765554 102765838
            PALE: 102880437(HMCN2) 102887819(HMCN1)
            MDO: 100024634(HMCN1)
            SHR: 100924223(HMCN1) 100934135(HMCN2)
            GGA: 429823(HMCN1)
            MGP: 100549629
            TGU: 100221486(HMCN2) 100228675(HMCN1)
            FAB: 101814883(HMCN1) 101820832(HMCN2)
            PHI: 102106898(HMCN1) 102110036(HMCN2)
            APLA: 101789391(HMCN2) 101789987 101793127(HMCN1)
            FPG: 101921415(HMCN1)
            FCH: 102054808(HMCN1)
            CLV: 102089780(HMCN2) 102096075(HMCN1)
            ASN: 102371562(HMCN1) 102374401(HMCN2)
            AMJ: 102568392(HMCN1) 102568745(HMCN2)
            PSS: 102460858(HMCN1) 102461330(HMCN2)
            CMY: 102939439(HMCN2) 102942956(HMCN1)
            ACS: 100555616(hmcn1)
            PBI: 103066354(HMCN1)
            XTR: 100135378(hmcn1) 100490941(hmcn2)
            DRE: 100536583 559150(hmcn1)
            TRU: 101066168 101073929
            MZE: 101478920 101481170
            OLA: 101165068 101172646
            XMA: 102235049 102237800
            LCM: 102350103(HMCN1) 102351448
            CMK: 103180075(hmcn1)
            BFO: BRAFLDRAFT_74468 BRAFLDRAFT_88754
            CIN: 100186133(hmcn1)
            SPU: 574679(HMCN1)
            BMOR: 101742719
            PHU: Phum_PHUM080420
            ISC: IscW_ISCW010083
            CEL: CELE_F15G9.4(him-4)
            CBR: CBG16045(Cbr-him-4)
            LOA: LOAG_02063 LOAG_02064 LOAG_05722 LOAG_07292
            TSP: Tsp_05833 Tsp_12667
            AQU: 100632616 100640592
REFERENCE   PMID:22771579
  AUTHORS   Feitosa NM, Zhang J, Carney TJ, Metzger M, Korzh V, Bloch W, Hammerschmidt M
  TITLE     Hemicentin 2 and Fibulin 1 are required for epidermal-dermal junction formation and fin mesenchymal cell migration during zebrafish development.
  JOURNAL   Dev Biol 369:235-48 (2012)
///
